Insider Buy/Sell Details for the Biotechnology Industry — September 2026
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (974)
Alto Neuroscience, Inc. (ANRO)
Smith Nicholas Conrad — PRESIDENT AND CFO
Shares
886
Price
$26.87
Total Value
$23.81K
Shares Held After
24,060
% of Holdings
3.6%
Alto Neuroscience, Inc. (ANRO)
Smith Nicholas Conrad — PRESIDENT AND CFO
Shares
23,170
Price
$25.78
Total Value
$597.29K
Shares Held After
24,946
% of Holdings
48.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$546.23
Total Value
$196.64K
Shares Held After
326,363
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$545.13
Total Value
$501.52K
Shares Held After
326,723
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
840
Price
$544.05
Total Value
$457.00K
Shares Held After
327,643
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$543.25
Total Value
$325.95K
Shares Held After
328,483
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
580
Price
$541.76
Total Value
$314.22K
Shares Held After
329,083
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$540.78
Total Value
$259.57K
Shares Held After
329,663
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$538.65
Total Value
$21.55K
Shares Held After
330,143
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$537.67
Total Value
$107.53K
Shares Held After
330,183
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$536.52
Total Value
$85.84K
Shares Held After
330,383
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$531.11
Total Value
$84.98K
Shares Held After
330,543
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$526.09
Total Value
$42.09K
Shares Held After
330,703
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$524.62
Total Value
$41.97K
Shares Held After
330,783
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$523.36
Total Value
$41.87K
Shares Held After
330,863
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$517.16
Total Value
$41.37K
Shares Held After
330,943
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$514.90
Total Value
$41.19K
Shares Held After
331,023
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$511.37
Total Value
$20.45K
Shares Held After
331,103
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$495.32
Total Value
$19.81K
Shares Held After
331,143
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$487.79
Total Value
$39.02K
Shares Held After
331,183
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$482.36
Total Value
$77.18K
Shares Held After
331,263
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
601
Price
$480.79
Total Value
$288.96K
Shares Held After
331,423
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
359
Price
$479.67
Total Value
$172.20K
Shares Held After
332,024
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
650
Price
$478.47
Total Value
$311.00K
Shares Held After
332,383
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
749
Price
$477.43
Total Value
$357.59K
Shares Held After
333,033
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
161
Price
$476.14
Total Value
$76.66K
Shares Held After
333,782
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
207
Price
$554.70
Total Value
$114.82K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
113
Price
$553.78
Total Value
$62.58K
Shares Held After
324,650
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$552.63
Total Value
$66.32K
Shares Held After
324,763
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$551.50
Total Value
$88.24K
Shares Held After
324,883
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$550.47
Total Value
$220.19K
Shares Held After
325,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$549.40
Total Value
$131.86K
Shares Held After
325,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$548.25
Total Value
$153.51K
Shares Held After
325,683
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$547.29
Total Value
$218.92K
Shares Held After
325,963
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
2,075
Price
$33.76
Total Value
$70.04K
Shares Held After
139,914
% of Holdings
1.5%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
7,925
Price
$33.04
Total Value
$261.81K
Shares Held After
141,989
% of Holdings
5.3%
Adlai Nortye Group Ltd. (ANL)
Ji Ping — Director
Shares
5,000
Price
$15.95
Total Value
$79.75K
Shares Held After
121,453
% of Holdings
4.0%
Adlai Nortye Group Ltd. (ANL)
Ji Ping — Director
Shares
5,000
Price
$16.03
Total Value
$80.15K
Shares Held After
126,453
% of Holdings
3.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
32,000
Price
$98.12
Total Value
$3.14M
Shares Held After
214,209
% of Holdings
13.0%
Alto Neuroscience, Inc. (ANRO)
Smith Nicholas Conrad — PRESIDENT AND CFO
Shares
110,830
Price
$26.58
Total Value
$2.95M
Shares Held After
24,060
% of Holdings
82.2%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
301
Price
$204.72
Total Value
$61.62K
Shares Held After
52,559
% of Holdings
0.6%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
1,199
Price
$203.91
Total Value
$244.48K
Shares Held After
52,860
% of Holdings
2.2%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
1,000
Price
$202.81
Total Value
$202.81K
Shares Held After
54,059
% of Holdings
1.8%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
1,609
Price
$201.72
Total Value
$324.57K
Shares Held After
55,059
% of Holdings
2.8%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
2,200
Price
$200.82
Total Value
$441.80K
Shares Held After
56,668
% of Holdings
3.7%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$27.06
Total Value
$202.92K
Shares Held After
32,316
% of Holdings
18.8%
Legend Biotech Corp (LEGN)
Sanders Corazon (Corsee) D. — Director
Shares
27,370
Price
$9.46
Total Value
$258.92K
Shares Held After
52,731
% of Holdings
34.2%
Adlai Nortye Group Ltd. (ANL)
Ji Ping — Director
Shares
214
Price
$15.77
Total Value
$3.37K
Shares Held After
131,453
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$486.77
Total Value
$97.35K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$482.28
Total Value
$57.87K
Shares Held After
324,643
% of Holdings
0.0%
Showing 1–50 of 974 transactions (page 1 of 20)